Oncopeptides announces the market potential for Pepaxti in Europe ...Middle East

PR Newswire - News
STOCKHOLM, Nov. 9, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces the estimated market potential for Pepaxti® in Europe. The potential...

Hence then, the article about oncopeptides announces the market potential for pepaxti in europe was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Oncopeptides announces the market potential for Pepaxti in Europe )

Apple Storegoogle play

Last updated :

Also on site :